Related Experiment Video
Updated: Apr 28, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
649
Carinal resection and reconstruction in thoracic malignancies
Sumin Shin1, Joon Suk Park, Young Mog Shim
1Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Journal of Surgical Oncology
|June 4, 2014
Summary
Carinal surgery for malignant tumors offers acceptable outcomes. Patients with thoracic malignancy involving the carina can be surgical candidates, with 5-year survival rates of 66.3% overall and 52.9% disease-free.
Area of Science:
- Thoracic surgery
- Surgical oncology
- Pulmonary medicine
Background:
- Malignant tumors involving the carina present complex surgical challenges.
- Establishing effective management guidelines is crucial for improving patient outcomes.
Purpose of the Study:
- To present clinical outcomes of carinal resection and reconstruction for malignant tumors.
- To inform the development of management guidelines for these rare conditions.
Main Methods:
- Retrospective analysis of 30 patients who underwent carinal resection and reconstruction between 1996 and 2011.
- Inclusion of non-small cell lung cancer (NSCLC) and salivary gland-type carcinomas.
Main Results:
- No in-hospital mortalities; 11 postoperative morbidities (including 3 ARDS) and 8 late complications (including 3 anastomotic stenosis).
- 12 mortalities during follow-up (6 cancer-related).
- 5-year overall survival (OS) of 66.3% and disease-free survival (DFS) of 52.9%.
Conclusions:
- Carinal surgery can effectively control malignant tumors involving the carina with acceptable mortality and morbidity.
- Surgical candidacy should be based on disease extent and patient functional status.
